Health Care & Life Sciences » Healthcare Provision | Bioanalytical Systems Inc.

Bioanalytical Systems Inc. | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,304.00
981.00
438.00
386.00
434.00
773
Total Accounts Receivable
4,312.00
3,435.00
4,014.00
2,240.00
3,145.00
5,140
Inventories
1,379.00
1,564.00
1,466.00
1,453.00
913.00
1,182
Other Current Assets
238.00
675.00
773.00
798.00
814.00
966
Total Current Assets
7,233.00
6,655.00
6,691.00
4,877.00
5,306.00
8,061
Net Property, Plant & Equipment
16,913.00
15,949.00
15,989.00
16,136.00
14,965.00
16,610
Long-Term Note Receivable
-
-
-
51.00
87.00
115
Intangible Assets
1,383.00
1,009.00
1,009.00
38.00
38.00
6,390
Other Assets
68.00
161.00
126.00
27.00
21.00
30
Total Assets
25,597.00
23,774.00
23,815.00
21,129.00
20,417.00
31,268
ST Debt & Current Portion LT Debt
2,296.00
1,267.00
1,102.00
5,140.00
352.00
Accounts Payable
3,584.00
2,672.00
2,858.00
2,965.00
2,052.00
Income Tax Payable
30.00
20.00
30.00
13.00
20.00
Other Current Liabilities
5,116.00
5,508.00
5,313.00
5,355.00
5,299.00
Total Current Liabilities
11,026.00
9,467.00
9,303.00
13,473.00
7,723.00
Long-Term Debt
5,112.00
4,750.00
3,734.00
198.00
4,227.00
Other Liabilities
-
21.00
50.00
-
-
Total Liabilities
16,138.00
14,238.00
13,087.00
13,671.00
11,950.00
Common Equity (Total)
8,124.00
8,351.00
9,543.00
6,273.00
7,432.00
Total Shareholders' Equity
9,459.00
9,536.00
10,728.00
7,458.00
8,467.00
Total Equity
9,459.00
9,536.00
10,728.00
7,458.00
8,467.00
Liabilities & Shareholders' Equity
25,597.00
23,774.00
23,815.00
21,129.00
20,417.00
Preferred Stock (Carrying Value)
1,335.00
1,185.00
1,185.00
1,185.00
1,035.00

About Bioanalytical Systems

View Profile
Address
2701 Kent Avenue
West Lafayette Indiana 47906
United States
Employees -
Website http://www.basinc.com
Updated 07/08/2019
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing.